Director, Data Science (RWE & GenAI), Diagnostics Platform - Remote at Danaher Corporation

United States

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Advanced degree in Biomedical/Imaging Engineering, Computer Science, Data Science, or related field (PhD preferred; Master’s considered)
6+ years of experience post education in diagnostics, medtech, or biopharma
Demonstrated expertise building production LLM systems: RAG, fine-tuning, tool-use/agents, prompt engineering, evaluation (faithfulness, factuality), and optimization
Hands-on proficiency in Python/R and imaging/ML, causal/survival/longitudinal methods, and visualization tools
Proven experience analyzing RWE/RWD (EHR, claims, registries, device logs) for clinical, regulatory, or market access impact
Ability to travel – 20%

Responsibilities

Own the LLM/agent roadmap
Build governed multi-modal datasets (text, tabular, device logs, lab results, EHR/claims)
Develop and validate production-grade RAG, fine-tuned LLMs, and task-specific agents
Integrate results into products, studies, and evidence programs (scientific, regulatory, market access, and post-market)
Conduct RWE analytics of EHR/claims/registries/device telemetry to drive biomarker discovery and development
Communicate impact to clinical, technical, and executive audiences via clear narratives, dashboards, and publications/white papers
Orchestrate cross-OpCo, AI Enterprise, and academic/consortia collaborations; manage vendors and open-source participation where strategic

Skills

Danaher Corporation

Water quality, diagnostics, and identification solutions

About Danaher Corporation

Danaher Corporation operates in key markets such as water quality, product identification, and diagnostics. The company provides precision instruments and advanced purification technologies for analyzing and managing water, ensuring its safety in various environments. In product identification, Danaher specializes in laser marking, coding, and packaging solutions that help maintain product freshness and accurate labeling throughout the supply chain. In the diagnostics sector, Danaher offers tools and software that enhance diagnostic confidence, enabling healthcare providers to deliver effective care. What sets Danaher apart from competitors is its unique Danaher Business System, which focuses on continuous improvement and empowers employees to drive change. The company's goal is to consistently deliver high-performance products and solutions while maintaining leadership in its markets.

Washington, District of ColumbiaHeadquarters

1969Year Founded

IPOCompany Stage

Industrial & Manufacturing, Healthcare, Consumer GoodsIndustries

10,001+Employees

Risks

Increased competition from Roche and Abbott in AI-driven diagnostics.

Potential regulatory challenges in the EU for water quality sector.

Supply chain vulnerabilities affecting precision instruments sourcing.

Differentiation

Danaher's Danaher Business System drives continuous improvement and superior financial performance.

The acquisition of Cytiva enhances Danaher's capabilities in the biopharmaceutical sector.

Danaher's advanced purification technologies meet increasing demands for sustainable water management.

Upsides

Danaher's investment in AI-driven healthcare solutions boosts its diagnostics capabilities.

Cytiva acquisition expands Danaher's market share in the biopharmaceutical sector.

Point-of-care testing demand drives growth for Danaher's diagnostic tools and software.

Land your dream remote job 3x faster with AI

Try Jobo Free